MS Views and News

MS Views and News
Click Logo - MS Views & News is Dedicated to Providing You with Multiple Sclerosis News and Information

Thursday, April 21, 2011

MS in the News: AAN, CCSVI and Nutritional updates

If you are having trouble viewing this message, please Click Here

 undefined
 Today is: April 21, 2011

THIS e-Newsletter is NOW
reaching people in (84) Countries 


 ENJOY OUR NEW EASY TO READ
APPEARANCE 
Tell us what you think... 
 TOPICS this week include:
(21) Informational Links to CLICK.
CLICK on each LINK to READ. 
Also See this week's:
Podcast (webcast),
Listings of Pharmaceutical Resources,
Social Media, Learning Videos,
Alternative Therapies for Foot drop,
Vitamins and Cannabis,
Cooling Vest Programs,
And find the information found below for Continued information on future
ORAL MEDICATIONS, CCSVI, MS Views: Education Programs, and more
~~~~~~~~~~~~~~~~~~~~~~~~~~
  

"Providing You with
'MS Views and News', 
IS What We Do" _______________________________


CLICK BELOW TO DONATE
http://www.msviewsandnews.org/index.php?option=com_content&view=article&id=141&Itemid=99
outbind://235-00000000EBDCF4E43ED0D511850800105A0510E1C46CB000/index.php?option=com_jdonation&view=jdonation&Itemid=102


 WE are a NOT for Profit

MSV&N is a 501©(3) organization as recognized by the Internal Revenue Service. Your gift is tax deductible to the extent permitted by law.

  
      $$ DONATE PLEASE $$


  •          Every Dollar Counts







  •           Please click here 







  •   All Contibutions are Tax Deductible 





  •  xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx  
     UPDATED News and Information



    European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending the approval of AVONEX® PEN™ for patients with relapsing multiple sclerosis (MS)
    Apr 19, 2011







    Duke Researcher Receives $44,000 Grant for Multiple Sclerosis Research
    Apr 19, 2011







    Multiple sclerosis tied to low sun, mono virus
    Apr 19, 2011







    Recent MS study on CCSVI illustrates need for More Research...
    Apr 18, 2011







    Scripps closer to knocking-out, multiple sclerosis
    Apr 18, 2011







    Alternative and Traditional Resources found at "MS Views and News"
    Apr 17, 2011







    The man who secretly (and legally) grows 20 tonnes (one metric ton) of cannabis a year
    Apr 17, 2011







    Bioness for Foot Drop -
    Apr 17, 2011







    PREPARE for the Coming Summer Heat
    Apr 16, 2011







    MS Patients in Belgium, need Support
    Apr 16, 2011
    ~~~~~~~~~~~~~~~~~~~~~~ 







    AAN: Laquinimod Reduces Multiple Sclerosis Activity
    Apr 16, 2011







    Study: CCSVI may result from multiple sclerosis disease progression
    Apr 15, 2011







    Biogen Test Finds Tysabri Patients With 1% Risk of Getting Brain Disease
    Apr 15, 2011







    Study suggests CCSVI could be symptom of MS
    Apr 15, 2011







    Research providing critical insight into the prognosis and clinical treatment course of people with a certain subtype of Multiple Sclerosis (MS) discussed at AAN meetings
    Apr 15, 2011
     ~~~~~~~~~~~~~~~~~~~~~~







    High Rates of Celiac Disease in Multiple Sclerosis Patients
    Apr 15, 2011







    Country Star Julie Roberts Opens Up About Battle With Multiple Sclerosis
    Apr 15, 2011







    FIRST BLOG RADIO STATION for MS Support and Chat
    Apr 14, 2011







    Five-year Alemtuzumab Phase 2 Data Shows Large Percentage of MS Patients Remain Free of Clinically-Active Disease
    Apr 14, 2011







    Feel empowered about your relapsing MS therapy
    Apr 14, 2011
    ~~~~~~~~~~~~~~~~~~~~~~ 







    Biogen Idec’s oral multiple sclerosis candidate, BG-12 (dimethyl fumarate), met its primary endpoint in the first of two Phase III pivotal trials in patients with relapsing-remitting disease
    Apr 13, 2011
    =========================================================
     Current PODCAST: http://www.youtube.com/watch?v=GvsXWMeXwMo
    ==========================================================
    'MS Views and News' scheduled education programs:  
    1. on April 30th in Melbourne, Fl.
    2. on May 4th in Miami - (in Spanish)
    3. and on July 23rd - In Miami (in English)
    For further details on any of the above, write to info@msviewsandnews.org
    ~~~~~~~~~~~~~~~~~~~~~~~~
     On May 12th and 13th, there is a COMEDY being held in West Babylon, L.I. - NY - that will benefit MS research and education. Contact Stuart for details and ticket information soon. This is only a two-night perfomance and Stuart will be attending. 
    ==========================================================
    Pharmaceutical-Patient Resources
    Avonex - MS ActiveSource
    (800) 456-2255

    www.avonex.com
    ---------------------
    Betaseron - Betaplus MS Support
    (800) 788-1467

    www.betaseron.com
    ---------------------
    Copaxone - Shared Solutions
    (800) 887-8100

    www.sharedsolutions.com
    ---------------------
    Extavia - Patient Support
    (866) 925-2333

    www.extavia.com
    ---------------------
    Gilenya - Patient Support
    (877) 408-4974

    www.gilenya.com
    ---------------------
    Rebif  - MS LifeLines
    (877) 447-3243

    www.MSLifeLines.com  ---------------------
    Novantrone -
    (877) 447-3243

    www.novantrone.com
    ---------------------
    Tysabri -TOUCH  Program
    (800) 456-2255

    www.tysabri.com   
    ========================================================
     SOCIAL MEDIA and Other Learning Methods


    Find us on  Facebook at our  primary page: facebook.com/msviewsandnews 

    FACEBOOK CHATROOMS

    For all affected by MS, Click: http://goo.gl/S3oO   

    For Caregivers, Click: http://goo.gl/b1GVr  

    For the Patient with a progressive form of MSClick: http://goo.gl/1MnI8 
    Find Stuart on Facebook: facebook.com/stuart.schlossman
    ========================================================
    WATCH our archived Podcasts (webcasts)
    ```````````````````````````````````
    Visit our Online Charity Auctions regularly, and please bid. We always have a lot of wonderful things up for sale.  Maybe you will find something for yourself or, perhaps, a gift for someone else. 
    ```````````````````````````````````````````` 
    SEE Patient and MS learning Videoshttp://wwwmsviewsandrelatednews.blogspot.com/
    Scroll to the bottom of the blog-page to see all the videos found there, for you to learn from.
    Come back to see us next week and please tell others of our new easy to read look  





    ====================
    Visit Our Blog, Bookmark the website and review each week's informational M.S. postings by Clicking here


     ==================
    SHARE OUR WEBSITE and BLOG
    Facebook and Twitter 
    information and Website
    addresses (URL's)  
    WITH OTHERS 
    ================
    TIME and Effort are put into each week's  e-newsletters and podcast series. 
     
    Please share the information we provide to educate and inform, with others. 




     Sponsorships for this e-Newsletter and our
    podcast series, are provided by:  
    undefined 
     ================================

    OUR MISSION:  'MS Views and News' (MSVN)  is dedicated to the global collection and distribution of current information concerning Multiple Sclerosis.  In collaboration with other organizations, 'MS Views and News' uses state-of-the-art communication channels to provide information for those affected by, or interested in MS.

    -Newsletter Disclaimer:
    ***Editor's Note: The intent of this newsletter is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.











    If you no longer wish to receive these emails, or you wish to update your profile, please click here.

    No comments:

    Post a Comment

    Leave comments only that directly pertain to each article.
    All solicitations will be removed.